Form4insider filings, from the source

SEC Form 4 · accession 0001225208-15-006630

BOSTON SCIENTIFIC CORP · BSX

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Maulik Nanavaty
Officer — SVP & Pres, Neuromodulation
Period of report
Feb 27, 2015
Accepted (ET)
Mar 3, 2015 · 5:17 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000885725

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1,F2Feb 27, 2015M3,981$0.00A131,013D
Common StockF1,F2Feb 27, 2015M2,389$0.00A133,402D
Common StockF2Feb 27, 2015F2,395$16.90D131,007D
Common StockF1,F2Feb 28, 2015M3,383$0.00A134,390D
Common StockF1,F2Feb 28, 2015M2,269$0.00A136,659D
Common StockF2Feb 28, 2015F2,125$16.90D134,534D

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Deferred Stock UnitsF1,F3—Feb 27, 2015M3,981D—Feb 27, 2015Common Stock3,9810D
Deferred Stock UnitsF1,F4—Feb 27, 2015M2,389D—Feb 27, 2017Common Stock2,3894,778D
Deferred Stock UnitsF1,F5—Feb 28, 2015M2,269D—Feb 28, 2016Common Stock2,2692,270D
Deferred Stock UnitsF1,F6—Feb 28, 2015M3,383D—Feb 28, 2018Common Stock3,38310,149D

Explanation of responses